Hyperactivity of osteoclast precursors in acute charcot osteoarthropathy

Hyperactivity of osteoclast precursors in acute charcot osteoarthropathy

Detalles Bibliográficos
Main Authors:	Mabilleau, G, Petrova, N, Edmonds, M, Sabokbar, A
Formato:	Journal article
Publicado:	2008

Títulos similares

RANKL plays an important role as activator of osteoclastic bone resorption in acute Charcot osteoarthropathy
por: Petrova, N, et al.
Publicado: (2007)

Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand
por: Mabilleau, G, et al.
Publicado: (2008)

Increased osteoclastic activity in acute Charcot's osteoarthropathy: the role of receptor activator of nuclear factor-kappaB ligand.
por: Mabilleau, G, et al.
Publicado: (2008)

Increased percentage of CD14+monocytes in acute Charcot osteoarthropathy
por: Petrova, N, et al.
Publicado: (2008)

The number of CD14+osteoclast precursors in acute charcot patients is correlated to the serum levels of tnf-alpha
por: Mabilleau, G, et al.
Publicado: (2009)

Inhibition of TNF-α Reverses the Pathological Resorption Pit Profile of Osteoclasts from Patients with Acute Charcot Osteoarthropathy
por: Nina L. Petrova, et al.
Publicado: (2015-01-01)

Number of circulating CD14-positive cells and the serum levels of TNF-α are raised in acute charcot foot.
por: Mabilleau, G, et al.
Publicado: (2011)

The Evaluation of SPECT-CT in the Early Management of Acute Charcot Osteoarthropathy (CN)
por: Raju S. Ahluwalia FRCS (Tr&Orth), MBBS, BSc, et al.
Publicado: (2016-08-01)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation
por: Mabilleau, G, et al.
Publicado: (2009)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
por: Mabilleau, G, et al.
Publicado: (2009)

Interleukin-32 promotes osteoclast differentiation but not osteoclast activation.
por: Guillaume Mabilleau, et al.
Publicado: (2009-01-01)

Rare complication of rheumatoid arthritis: Charcot Neuro-osteoarthropathy
por: Zhiyuan Luo, et al.
Publicado: (2024-04-01)

The pathogenesis of Charcot osteoarthropathy: the role of the peripheral nervous system
por: Galstyan Gagik Radikovich, et al.
Publicado: (2015-01-01)

A Rare Charcot Neuro-Osteoarthropathy of Hip with an Uncommon Cause
por: Chandran Vijay, et al.
Publicado: (2023-04-01)

Pathomorphological and pathochemical characteristic of the osteomyelitis focus in patients with diabetic osteoarthropathy (Charcot foot)
por: A. S. Sudnitsyn, et al.
Publicado: (2022-10-01)

Criteria of immobilization duration of the affected foot in diabetic Charcot neuro-osteoarthropathy
por: Anastasia Gennad'evna Demina, et al.
Publicado: (2014-12-01)

Bone Defect Replacement in Diabetic Neuropathic Osteoarthropathy (Charcot Foot): Review
por: Petr S. Bardiugov, et al.
Publicado: (2023-09-01)

Humoral factors act directly on circulating osteoclast precursors to control osteoclast formation
por: Hirayama, T, et al.
Publicado: (2000)

Features of organotopic remodeling of bone tissue and implanted osteoplastic material in Charcot neuro/osteoarthropathy
por: Stanislav A. Osnach, et al.
Publicado: (2023-08-01)

Salvage of Chronic Therapy‐Resistant Bilateral Charcot Foot Osteoarthropathy with Signs of Osteomyelitis
por: Ariel Kidron, et al.
Publicado: (2022-07-01)

Osteoclast formation from circulating precursors in osteoporosis.
por: Jevon, M, et al.
Publicado: (2003)

The human osteoclast precursor circulates in the monocyte fraction.
por: Fujikawa, Y, et al.
Publicado: (1996)

Long-Term Changes in Sarcopenia and Body Composition in Diabetes Patients with and without Charcot Osteoarthropathy
por: Michael Zaucha Sørensen, et al.
Publicado: (2022-01-01)

BISPHOSPHONATES AFFECT HUMAN OSTEOCLAST DEVELOPMENT IN VITRO
por: Mabilleau, G, et al.
Publicado: (2010)

Osteoclast formation from circulating precursors in primary and secondary osteoporosis.
por: Jevon, M, et al.
Publicado: (2000)

Charcot neuro-osteoarthropathy: a review of key concepts and an evidence-based surgical management algorithm
por: Miltiadis Argyropoulos, et al.
Publicado: (2024-08-01)

Osteoclastic responses to phase pure hydroxyapatite (HA) and silicon (SI)-substituted HA
por: Mabilleau, G, et al.
Publicado: (2007)

Gender- and age-related differences in osteoclast formation from circulating precursors.
por: Jevon, M, et al.
Publicado: (2002)

Osteoclast precursors at sites of pathological bone resorption are CD14+mononuclear phagocytes
por: Danks, L, et al.
Publicado: (2001)

Alendronate and ibandronate affect osteoclast formation and size differently from risedronate and zoledronate
por: Mabilleau, G, et al.
Publicado: (2011)

Hypertrophic osteoarthropathy
por: Gang Wang, et al.
Publicado: (2023-02-01)

Syringomyelic osteoarthropathy
por: Зуев В.В ., et al.
Publicado: (2012-06-01)

1,25-Dihydroxyvitamin D(3) and prostaglandin E(2) act directly on circulating human osteoclast precursors.
por: Itonaga, I, et al.
Publicado: (1999)

Early diagnosis of Charcot neuro-osteoarthropathy using MRI and its effect on patient outcomes: A seven-year retrospective audit
por: Laksh Lukkhoo, et al.
Publicado: (2024-07-01)

Major sex and age differences in human osteoclast formation from circulating precursors: Implications for the pathogenesis of primary osteoporosis
por: Fujikawa, Y, et al.
Publicado: (1999)

Gender differences in 1,25-dihydroxyvitamin D3 effects on osteoclast formation from circulating and bone marrow precursors.
por: Jevon, M, et al.
Publicado: (2001)

TSG-6 regulates bone remodeling through inhibition of osteoblastogenesis and osteoclast activation.
por: Mahoney, D, et al.
Publicado: (2008)

TSG-6 regulates bone remodelling through inhibition of osteoblastogenesis and osteoclast activation
por: Mahoney, D, et al.
Publicado: (2008)

Primary hypertrophic osteoarthropathy
por: E. L. Trisvetova
Publicado: (2020-11-01)

Osteoarthropathy of the front thorax
por: Nikolay V. Bunchuk
Publicado: (2023-01-01)